Pharmaceutical manufacturing and research operations across Belgium and Luxembourg
Novartis Belux runs a 1,750-person manufacturing and research footprint across three Belgian sites, including a production facility in Puurs. The tech stack reflects a capital-intensive, heavily regulated operation: Siemens PLC, SCADA, HMI, and SAP dominate, with active projects in automation, energy efficiency, and production MES implementation (GMT). Hiring skews engineering-heavy (17 of 32 open roles), signaling sustained investment in plant modernization and legacy-system replacement.
Notable leadership hires: Business Workstream Lead, QC Chemistry Team Lead
Novartis Belux is the Belgian and Luxembourg arm of Novartis, a global pharmaceutical company. The organization operates manufacturing, research, and quality-assurance functions across three locations, with a significant production site in Puurs. Core therapeutic focus includes cardiovascular, renal and metabolic, oncology, immunology, and neuroscience. The organization is actively modernizing production infrastructure through automation, MES consolidation, and SAP system migration, while managing compliance and sustainability mandates in a highly regulated industry.
Novartis Belux operates three locations in Belgium, including a production site in Puurs, with over 1,750 employees. The organization manufactures medicines across core therapeutic areas including oncology, immunology, and cardio-metabolic disease.
The stack includes Siemens PLC, SCADA, HMI, SAP, AutoCAD, Revit, and CMMS. Current projects involve deploying GMT as a production MES and migrating from SAP-PEP to SAP S/4HANA.
Other companies in the same industry, closest in size